Skip to main content
    R

    Rezolute Inc (RZLT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.01
    +0.43 (+12.15%)

    Market Cap: $346.29M

    Last updated: Nov 17, 2026 at 4:43 PM ET

    Rezolute Inc (RZLT) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Rezolute (RZLT) has a market cap of $346.29M and an enterprise value of $338.14M. It has 104.78M shares outstanding.

    Total Valuation

    Enterprise value is 2.35% below the market cap, as cash exceeds debt.

    Market Cap$346.29M
    Enterprise Value$338.14M
    Latest price (Nov 17, 2026)$4.01

    Key Dates

    The next earnings report is expected on Feb 10, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 10, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndJune

    Share Statistics

    The share count grew 26.79% a year over 3 years.

    Shares Outstanding104.78M
    Shares Change (YoY)+1.31%
    Share Count Growth (3Y CAGR)+26.79%

    Valuation Ratios

    Forward P/S150.3x
    P/B Ratio4.9x

    Price Statistics

    The stock is down 59.32% over 52 weeks and trades 0.74% below its 50-day average.

    Beta (1Y)1.11
    52-Week Change-59.32%
    1-Month Change+8.51%
    3-Month Change-14.94%
    6-Month Change+29.52%
    5-Year Change-38.28%
    10-Year Change-93.42%
    Total Return (1Y)-59.32%
    Total Return (5Y CAGR)-7.79%
    Return vs SPY (1Y)-72.04%
    Max Drawdown (1Y)-87.20%
    Max Drawdown (3Y)-87.20%
    Sharpe Ratio (1Y)-0.41
    Correlation with SPY (1Y)0.07
    50-Day Average$4.04
    200-Day Average$3.93
    52-Week Range$1.07 to $11.16
    RSI (14 Days)51.4
    Average Volume (20 Days)1.69M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 9.92x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio9.92x
    Quick Ratio9.92x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -90.66% over the last 12 months, against a 5-year average of -50.32%.

    Return on Equity (ROE)-90.66%
    Return on Assets (ROA)-81.16%
    ROE (5Y Average)-50.32%
    ROA (5Y Average)-46.31%
    ROIC (5Y Average)-41.97%

    Scores

    RZLT has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Operating Income-$82.53M
    Pretax Income-$77.92M
    Net Income-$77.92M
    Reported EPS (TTM)-$0.76

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 89.52% of the $96.01M in total assets.

    Cash and Equivalents$8.15M
    Total Debt$0
    Net Cash$8.15M
    Net Cash Per Share$0.08
    Working Capital$84.37M
    Shareholder Equity$85.95M
    Book Value Per Share$0.82
    Total Assets$96.01M
    Total Liabilities$10.06M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$65.99M
    FCF Per Share-$0.68
    Depreciation and Amortization$2.16M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Dividends and Yields

    RZLT does not pay a dividend.

    Buyback Yield0.00%
    Shareholder Yield0.00%

    Stock Splits

    The last split was a 1-for-50 reverse split on Oct 13, 2020.

    Last Split DateOct 13, 2020
    Split TypeReverse split
    Split Ratio1:50

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About RZLT

    What is RZLT's market cap?

    Rezolute has a market cap of $346.29M. Its enterprise value, which adds debt and subtracts cash, is $338.14M.

    How many shares of RZLT are outstanding?

    Rezolute has 104.78M shares outstanding. The count is up 1.31% from a year earlier.

    Does RZLT pay a dividend?

    No. Rezolute does not pay a dividend.

    How much debt does RZLT have?

    Rezolute has $0 of total debt and $8.15M of cash and equivalents, a net cash position of $8.15M.